title: Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
authors.forename: Robert
authors.initials: R
authors.lastname: Griffiths
authors.forename: Michelle
authors.initials: M
authors.lastname: Gleeson
authors.forename: Carolina
authors.initials: C
authors.lastname: Reyes
authors.forename: Kevin
authors.initials: K
authors.lastname: Knopf
authors.forename: Mark
authors.initials: M
authors.lastname: Danese
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003625:Data Collection; D016208:Databases, Factual; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008224:Lymphoma, Follicular / Q000188:drug therapy* / Q000401:mortality*; D008297:Male; D015999:Multivariate Analysis; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D015996:Survival Rate; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone